Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 19.09.2023       Diversified Energy PLC

First Berlin Equity Research has published a research update on Diversified Energy PLC (ISIN: GB00BYX7JT74). Analyst Simon Scholes reiterated his BUY rating and maintained his GBp 180.00 price target. Abstract: H1/23 results once again demonstrated the effectiveness of DEC's business model in delivering high profits irrespective of the level of [ … ]
Mon, 18.09.2023       PAION AG

First Berlin Equity Research has published a research update on PAION AG (ISIN: DE000A0B65S3). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 38.00 to EUR 11.00. Abstract: PAION's lead product remimazolam was first approved in January 2020 in Japan in the indication general anesthesia (GA). It has since  [ … ]
Mon, 18.09.2023       Haemato AG

First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 33,00 auf EUR 34,00. Zusammenfassung: Das Sechsmonatsbericht lag nahe an unseren Prognosen und verdeutlichte die schlankere operative Kostenstr [ … ]
Thu, 14.09.2023       HAEMATO AG

H1 2023: Turnover and EBIT above our expectations; forecasts and target price slightly raised; BUY rating confirmed   In the first half of 2023, HAEMATO AG achieved a revenue increase of 10.5 % to € 133.64 million (previous year: € 120.97 million) and thus exceeded our expectations. This sales development, which is separated accord [ … ]
Thu, 14.09.2023       Vectron Systems AG

H1 2023: 'On track': Turnover in line with expectations; EBITDA climbs significantly; GBC-Forecasts raised; Target price raised to €10.00 (previously: €9.40); Rating: BUY   The first six months of 2023 were marked by the consolidation of acardo group AG, which was acquired on 1st January 2023. acardo sales, which were consolidated  [ … ]
Tue, 12.09.2023       Media & Games Invest SE

First Berlin Equity Research hat ein Research Update zu Media and Games Invest SE (ISIN: SE0018538068) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 4,00 auf EUR 3,20. Zusammenfassung: Die Auswirkungen der schwachen Werbeausgaben standen im Mittelpunkt des Sechsmonatsberichts. Das w [ … ]
Mon, 11.09.2023       Media and Games Invest SE

HY1 2023: Solid sales development despite economic headwinds; stable operating earnings development due to strict cost management; GBC estimates and price target adjusted after guidance reduction   Business development in HY1 2023   Media and Games Invest SE (MGI) published its half-year figures for the current financial year on 31 Augu [ … ]
Wed, 06.09.2023       Knaus Tabbert AG

First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 83,00. Zusammenfassung: Wir haben den Caravan Salon 2023 in Düsseldorf besucht, um die neuesten Wohnmobile aus erster Hand zu se [ … ]
Mon, 04.09.2023       Aroundtown SA

First Berlin Equity Research hat ein Research Update zu Aroundtown SA (ISIN: LU1673108939) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 3,50. Zusammenfassung: AT ist in einem Jahr mit Gegenwind auf einem stabilen Weg geblieben und konnte in Q2 die gute operative Leistung  [ … ]
Wed, 30.08.2023       Cardiol Therapeutics Inc

First Berlin Equity Research has published a research update on Cardiol Therapeutics Inc. (ISIN: CA14161Y2006). Analyst Christian Orquera reiterated his BUY rating and maintained his USD 3.60 price target. Abstract: Cardiol Therapeutics has published its H1 2023 financial report. Overall figures were in line with our expectations. The company r [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 25.11.2024, Calendar Week 48, 330th day of the year, 36 days remaining until EoY.